Therapeutic targeting of tumor-associated myeloid cells synergizes with radiation therapy for glioblastoma

Tumor-associated myeloid cells (TAMCs) are key drivers of immunosuppression in the tumor microenvironment, which profoundly impedes the clinical response to immune-dependent and conventional therapeutic modalities. As a hallmark of glioblastoma (GBM), TAMCs are massively recruited to reach up to 50%...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Proc Natl Acad Sci U S A
Glavni autori: Zhang, Peng, Miska, Jason, Lee-Chang, Catalina, Rashidi, Aida, Panek, Wojciech K., An, Shejuan, Zannikou, Markella, Lopez-Rosas, Aurora, Han, Yu, Xiao, Ting, Pituch, Katarzyna C., Kanojia, Deepak, Balyasnikova, Irina V., Lesniak, Maciej S.
Format: Artigo
Jezik:Inglês
Izdano: National Academy of Sciences 2019
Teme:
PNAS Plus
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6876152/
https://ncbi.nlm.nih.gov/pubmed/31712430
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1073/pnas.1906346116
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items